Latest Schedule 13D activist filings

Rocca & Partners Stichting Administratiekantoor Aandelen San Faustin, San Faustin S.A., and Techint Holdings S.A R.L. have increased their beneficial ownership in Tenaris S.A. to 67.54% due to the company's recent share repurchases.

Controlling shareholders Joseph and Zwi Williger, along with their associated entities, have increased their beneficial ownership in G Willi Food International Ltd. to 75.73% through recent share acquisitions.

Tencent Holdings Limited and Tencent Mobility Limited have fully divested their beneficial ownership in Global Blue Group Holding AG by selling all Ordinary Shares for $7.50 per share.

1Globe Capital LLC and 1Globe Biomedical (Hong Kong) Company Limited filed Amendment No. 6 to their Schedule 13D for Sinovac Biotech Ltd., correcting previous errors and providing updates on ongoing litigation regarding beneficial ownership and corporate governance.

Atlas Capital Resources and its affiliated entities have increased their beneficial ownership in Greenidge Generation Holdings Inc. to approximately 24.2% of Class A Common Stock, primarily through the receipt of stock as interest payments.

Long-term shareholders Edward and Ludmila Smolyansky have initiated a definitive consent solicitation to replace the entire board of Lifeway Foods, including CEO Julie Smolyansky, and amend company bylaws to prohibit family employment.

Palogic Value Fund, L.P. and affiliated entities have reported the sale of over 2.7 million shares of Open Lending Corp common stock in June and July 2025, decreasing their beneficial ownership to 3.5%.

Geveran Investments Limited and its affiliated entities have reduced their beneficial ownership in KLX Energy Services Holdings, Inc. to below 5% through recent share sales, marking their exit as a major shareholder.

Glencore plc's indirect subsidiary, Danelo Limited, has acquired a 16.4% beneficial ownership stake in Bunge Global SA, comprising over 32.8 million shares and a significant cash payment, as part of the previously announced business combination with Viterra Limited.

Nvni Group Limited's Chief Financial Officer, Luiz Busnello, increased his beneficial ownership to 5.55% of Ordinary Shares through the conversion of advisory compensation into equity and internal share reallocations.

Cohen Circle Sponsor II, LLC, Cohen Circle Advisors II, LLC, and Betsy Z. Cohen have disclosed a combined beneficial ownership of 26.28% in Cohen Circle Acquisition Corp. II, primarily through Class B ordinary shares, following the company's initial public offering.

Nvni Group Limited's CEO and Chair, Pierre Schurmann, updated his beneficial ownership, reflecting internal share reallocations and the conversion of $630,000 in advisory compensation into 1.46 million ordinary shares.

A group of significant shareholders, including Prescott General Partners LLC and Thomas W. Smith, updated their beneficial ownership in World Acceptance Corporation, disclosing a recent distribution of shares.

A group of significant shareholders, including Prescott General Partners LLC and Thomas W. Smith, filed an Amendment No. 13 to their Schedule 13D, detailing updated beneficial ownership in Credit Acceptance Corporation and recent share transactions.

Major shareholders of Emeren Group Ltd, including Shah Capital, have formally committed to voting their significant equity stakes in favor of the company's merger with Shurya Vitra Ltd, enhancing transaction certainty.

Enstar Group Limited has completed its merger, resulting in shareholders receiving $338 per share in cash, and the company is initiating the process to delist its Ordinary Shares from NASDAQ and deregister with the SEC.

Enstar Group LTD has completed its acquisition by investment vehicles managed or advised by affiliates of Sixth Street Partners LLC, leading to the delisting of its Ordinary Shares and Depositary Shares from NASDAQ.

Enstar Group Limited has completed its acquisition by investment vehicles managed by Sixth Street Partners LLC, resulting in shareholders receiving $338 per share in cash and the company initiating delisting from NASDAQ.

FIGX Acquisition Partners LLC and CEO Louis Gerken have jointly filed a Schedule 13D, disclosing a combined beneficial ownership of 21.5% of FIGX Capital Acquisition Corp.'s ordinary shares, acquired for investment purposes.

DCM Ventures China Fund and its affiliated entities have significantly reduced their beneficial ownership in QuantaSing Group Ltd, selling approximately 1.5 million American Depositary Shares (ADS) and decreasing their aggregate stake by over one percent to 21.4%.

A tender offer for Global Blue Group Holding AG by Shift4 Payments, Inc.'s Merger Sub has successfully concluded, leading to the sale of significant stakes by CK Opportunities Wolverine and the resignation of a board member.

Christopher Harborne and Klear Kite LLC have filed an Amendment No. 8 to their Schedule 13D, disclosing a continued beneficial ownership of 7.2% of Innovative Solutions & Support Inc.'s common stock.

Ant International Technologies (Hong Kong) Holding Limited has tendered all its Ordinary Shares in Global Blue Group Holding AG, ceasing to be a beneficial owner as of July 3, 2025.

A group of entities led by Yorkville Acquisition Sponsor LLC has filed a Schedule 13D, disclosing beneficial ownership of 25.88% of Yorkville Acquisition Corp.'s ordinary shares, acquired for investment purposes.

1Globe Capital LLC and 1Globe Biomedical (Hong Kong) Company Limited, led by Dr. Chiang Li, have voted their significant stake against proposals to remove and replace the current board of Sinovac Biotech Ltd., highlighting ongoing corporate governance disputes and litigation.

Pelthos Therapeutics Inc. has filed an amended Schedule 13D, detailing updated beneficial ownership stakes for Ezra Friedberg, Balmoral Financial Group LLC, and Key Recovery Group LLC following a reverse stock split, a merger, and a private investment in public equity (PIPE) financing.

Saba Capital Management, L.P. and its affiliates have filed an amended Schedule 13D, disclosing a reduced beneficial ownership of 5.08% in Principal Real Estate Income Fund, following significant share sales.

Silver Lake-affiliated entities have fully divested their beneficial ownership in Global Blue Group Holding AG after tendering all their Ordinary and Series A Preferred Shares in a recently completed tender offer by Merger Sub.

Ligand Pharmaceuticals Incorporated has become a significant beneficial owner of Pelthos Therapeutics Inc., holding 49.9% of its common stock, following the completion of a merger and a private investment in public equity (PIPE) financing.

Ligand Pharmaceuticals Incorporated has become a significant beneficial owner of Pelthos Therapeutics Inc., holding 49.9% of its common stock, following the completion of a merger and a private investment in public equity (PIPE) financing.